The Gross Margin of Mithra Pharmaceuticals SA (MITRA.BR) is 45.34%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 45.34% |
2022-12-31 | 70.71% |
2021-12-31 | 30.63% |
2020-12-31 | 61.72% |
2019-12-31 | 97.42% |
2018-12-31 | 97.29% |
2017-12-31 | 91.90% |
2016-12-31 | 59.81% |
2015-12-31 | 50.11% |
2014-12-31 | 31.63% |